Beacon Oncology provides comprehensive oncology drug and trial coverage and is designed to help pharmaceutical and biotech companies make faster and more informed decisions to improve drug development success rates.

Beacon has launched Beacon Oncology, a comprehensive database designed to support oncology drug development scientists working at biotech and pharmaceutical companies across the world.

With access to 25,000+ drugs and 50,000+ clinical trials, Beacon Oncology is the most complete oncology database in the world, offering unprecedented insights into the complex landscape of oncology research and development.

Supporting Drug Development Scientists in the Fight to Develop Effective Drugs Efficiently.

In an era where the competition in oncology drug development is at an all-time high, the need for accurate, comprehensive, and timely data has never been greater. The probability of successfully bringing an oncology drug to market is estimated to be less than 4%, making strategic decision-making crucial for R&D success.

Through its database, Beacon is addressing this challenge by equipping scientists with curated, structured, and highly searchable data that enables them to:

  • Identify emerging trends in oncology drug development
  • Track competitor activity and benchmarking progress
  • Optimize drug development strategies with robust clinical trial insights
  • Reduce time spent on data collection and analysis
  • Make informed decisions faster, improving the likelihood of success

By providing visibility into the oncology landscape across all drug modalities, Beacon Oncology empowers scientists to navigate the complexities of drug discovery and development with confidence.

Data from Early-Stage Research to Late-Phase Clinical Trials

Beacon Oncology is built on an advanced, user-friendly platform that consolidates oncology drug development data from early-stage research to late-phase clinical trials. The database offers:

  • Unparalleled Data Accuracy – Derived from proprietary technologies and expert curation, ensuring the highest level of reliability.
  • Comprehensive Coverage – Providing 20% more drugs and trials than the nearest competitor.
  • Modality-Specific Ontologies – Enabling precise insights across the oncology treatment landscape.
  • Structured and Searchable Content – Offering over 30 filters to refine searches and analyze data effectively.
  • Manually Curated Data – Verified by experts for enhanced accuracy and success.

The database is updated daily, ensuring that users have access to the latest information on drugs and clinical trials in real time.

A Strategic Intelligence Tool designed to Accelerate Innovation and Improve Success Rates

Beacon Oncology is more than just a database. It is a strategic intelligence tool designed to accelerate innovation and improve success rates in oncology drug development. Key benefits include:

1. Enhanced Drug Development Strategy

Scientists can leverage Beacon Oncology’s comprehensive dataset to refine their research and prioritize the most promising drug candidates based on competitive insights and clinical trial outcomes.

2. Accelerated R&D Decision-Making

By offering structured and highly searchable data, Beacon Oncology reduces the time spent on research, allowing scientists to focus on groundbreaking discoveries and optimizing drug development timelines.

3. Competitive Advantage in Oncology Research

With up-to-date and curated intelligence, researchers can stay ahead of market trends, monitor competitor activities, and adapt their strategies accordingly to gain a competitive edge.

4. Increased Success Rates in Clinical Trials

Access to real-time clinical trial data enables scientists to identify the most effective trial designs and avoid potential pitfalls, thereby increasing the probability of successful drug approval.

5. Seamless Integration into Existing Workflows

Beacon Oncology is designed to integrate smoothly into existing research and development workflows, offering a user-friendly interface and powerful analytical tools to enhance productivity and collaboration.

Jake Morris, Account Manager at Beacon comments: “Beacon Oncology is set to revolutionize how scientists approach oncology drug development. By providing access to the most comprehensive dataset available, we’re enabling researchers to make more informed decisions faster, ultimately accelerating the path to breakthrough treatments. This is a major step forward for Beacon and for the entire oncology community.”

For further information on Beacon Oncology please visit https://beacon-intelligence.com/solutions/oncology/